申请人:BASF Aktiengesellschaft
公开号:US04288449A1
公开(公告)日:1981-09-08
Compounds of the formula 1 ##STR1## where R.sup.1 is a saturated, unsubstituted or substituted aliphatic radical of 1 to 8 carbon atoms, an unsaturated alkyl radical of 2 to 8 carbon atoms, a cycloalkyl radical of 3 to 7 carbon atoms in the ring or an alkyl radical of 1 to 4 carbon atoms which is substituted by phenyl or by a 5- or 6-membered aromatic heterocyclic ring containing an N, O or S atom, the phenyl ring or the heterocyclic ring itself being unsubstituted, monosubstituted or polysubstituted, and R.sup.2 is hydrogen or R.sup.1 and R.sup.2 together with the nitrogen are a 4-membered to 6-membered cycloaliphatic saturated heterocyclic ring, R.sup.3 is hydrogen or alkyl of 1 to 5 carbon atoms, R.sup.4 and R.sup.5 are identical or different and each is hydrogen or alkyl of 1 to 5 carbon atoms, X is oxygen, sulfur or >SO- or >NH- and Ar is unsubstituted, monosubstituted, disubstituted or trisubstituted phenyl, and their therapeutically useful ammonium salts, alkali metal salts or acid addition salts, which compounds and salts thereof exhibit valuable pharmacological properties, their preparation, therapeutic agents containing these products, and their use as drugs.
化合物的公式为1 ##STR1## 其中R.sup.1是1到8个碳原子的饱和,未取代或取代的脂肪基,2到8个碳原子的不饱和烷基,3到7个碳原子的环烷基或1到4个碳原子的烷基,其被苯基或含有N,O或S原子的5-或6元杂环芳香环取代,苯环或杂环本身未取代,单取代或多取代,R.sup.2是氢或R.sup.1和R.sup.2与氮一起是4个到6个成员的环脂肪饱和杂环,R.sup.3是氢或1到5个碳原子的烷基,R.sup.4和R.sup.5相同或不同,每个是氢或1到5个碳原子的烷基,X是氧,硫或>SO-或>NH-,Ar是未取代,单取代,二取代或三取代的苯基,以及它们的治疗有用的铵盐,碱金属盐或酸加成盐,这些化合物及其盐具有有价值的药理特性,它们的制备,含有这些产品的治疗剂,以及它们作为药物的用途。